CAR-MSCs (Mesoblast)

N/A

Report date: 2026/04/20 16:52:44

Base Information

Drug NameCAR-MSCs (Mesoblast)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy > Chimeric antigen receptor Mesenchymal stromal cells

Mechanisms of ActionStem cell replacements

TargetsUpdating

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMesoblast Inc

China Registration ClassN/A

Develop Information

Active CompaniesMesoblast Inc

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A